Martin-Martinez, Nuria
Caro-Cañizares, Irene
Carballo, Juan J.
Parellada, Mara
Funding for this research was provided by:
Universidad Complutense de Madrid
Article History
Received: 9 April 2025
Revised: 29 May 2025
Accepted: 9 June 2025
First Online: 25 June 2025
Declarations
:
: This study was conducted according to the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Gregorio Marañón (260–19-IP) and Fundación Jiménez Díaz University Hospitals (PIC120-19).
: Written informed consent was obtained from all individual participants included in the study and their parents or legal guardians.
: Dra. Mara Parellada has served in advisory or consultancy role for Exeltis, and Servier and she is involved in clinical trials promoted by Servier and for F. Hoffmann La Roche Ltd.The rest of the authors declare no competing interests.